Brucellosis in Livestock: Serological and Molecular Diagnostics for Eradication Programs

Introduction

Brucellosis is a chronic bacterial infection of livestock caused by members of the genus Brucella. In cattle, the primary etiological agent is Brucella abortus; in small ruminants (sheep and goats), Brucella melitensis predominates, although Brucella ovis causes epididymitis in rams and Brucella suis can infect swine and occasionally cattle [1, 2]. The disease is characterized by reproductive failure, including abortion in the last trimester, retained placenta, orchitis, and reduced milk yield [3]. Economic losses arise from decreased productivity, trade restrictions, and the cost of control programs [4].

Eradication programs rely on accurate diagnostic tests to identify infected animals, followed by removal (test-and-slash) or vaccination. Serological methods such as the Rose Bengal Plate Test (RBPT) and enzyme-linked immunosorbent assay (ELISA) are widely used for screening, while molecular techniques like polymerase chain reaction (PCR) provide confirmatory and discriminatory power [5, 6]. This article reviews the biological principles, performance characteristics, and operational roles of these diagnostic tools within the context of livestock brucellosis eradication.

Pathogen Biology and Host Interaction

Brucella species are Gram-negative, facultative intracellular coccobacilli that survive and replicate within host macrophages [7]. The lipopolysaccharide (LPS) of smooth Brucella strains (e.g., B. abortus biovars 1, 2, 4; B. melitensis biovars 1–3) contains O-polysaccharide chains that are the primary target of serological tests [8]. Rough strains (e.g., B. abortus RB51 vaccine) lack O-polysaccharide and are not detected by standard serological assays [9].

Infection occurs via ingestion or inhalation of contaminated materials. Bacteria invade the gastrointestinal or respiratory mucosa, are phagocytosed by macrophages, and traffic to regional lymph nodes before establishing persistent infection in the reproductive tract and mammary gland [10]. The intracellular niche protects Brucella from humoral immunity, making cell-mediated immunity critical for clearance [11]. Antibody responses develop within 2–4 weeks post-infection and are dominated by IgG1 in cattle [12].

Serological Diagnostics

Serological tests detect antibodies against Brucella LPS or whole-cell antigens. They are the backbone of surveillance due to low cost and high throughput.

Rose Bengal Plate Test (RBPT)

RBPT is a rapid agglutination test using stained B. abortus antigen at pH 3.6–3.7 [13]. The acidic pH reduces non-specific agglutination while preserving specific antibody binding. A positive reaction appears as visible clumping within 4 minutes. RBPT has high sensitivity (95–99%) but moderate specificity (85–95%) due to cross-reactions with Yersinia enterocolitica O:9, Escherichia coli O:157, and other Gram-negative bacteria [14, 15]. It is recommended by the World Organisation for Animal Health (WOAH) as a screening test for cattle and small ruminants [16].

Enzyme-Linked Immunosorbent Assay (ELISA)

ELISA formats include indirect ELISA (iELISA) and competitive ELISA (cELISA). iELISA uses whole-cell or purified LPS antigen coated on microtiter plates; serum antibodies are detected with anti-species conjugate [17]. cELISA uses monoclonal antibodies specific for Brucella O-polysaccharide, reducing cross-reactivity [18]. The sensitivity of iELISA ranges from 96–100% and specificity from 98–100% in cattle [19]. For small ruminants, cELISA is preferred due to lower background [20].

ELISA can be automated for high-throughput screening in eradication programs. The assay detects IgG, which persists for months to years after infection [21]. For a detailed discussion of ELISA principles, refer to the article on Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus.

Complement Fixation Test (CFT)

CFT was historically the confirmatory test but has been largely replaced by ELISA due to complexity and prozone effects [22]. It remains a prescribed test for international trade in some regions [23].

Comparative Performance

Molecular Diagnostics

PCR-based methods detect Brucella DNA directly from clinical samples (blood, milk, vaginal swabs, tissues). They offer high sensitivity and specificity, can differentiate species, and are unaffected by vaccination status [24].

Conventional PCR and Real-Time PCR

Target genes include bcsp31 (encoding a 31-kDa immunogenic protein), IS711 (insertion sequence), and omp2 (outer membrane protein) [25, 26]. Real-time PCR (qPCR) using SYBR Green or TaqMan probes provides quantification and reduces contamination risk [27]. The limit of detection for qPCR is approximately 10–100 colony-forming units per reaction [28].

Multiplex PCR

Multiplex PCR assays differentiate B. abortus, B. melitensis, B. suis, and B. ovis by amplifying species-specific markers such as BMEI0462, BMEI0755, and BMEI1072 [29]. This is valuable for epidemiological tracing and vaccine strain differentiation [30].

Sample Types and Pre-Analytical Considerations

Blood samples should be collected in EDTA tubes to prevent coagulation. Milk samples require centrifugation to remove fat and cellular debris [31]. DNA extraction using commercial kits yields high-quality DNA for downstream amplification [32]. PCR inhibitors in milk (e.g., calcium ions) can be mitigated by using internal amplification controls [33].

Performance in Eradication Programs

PCR is more sensitive than culture for detecting Brucella in milk and vaginal swabs [34]. In test-and-slash programs, PCR can identify infected animals before seroconversion, reducing the window for transmission [35]. However, PCR cannot distinguish live from dead bacteria, and false positives may occur due to environmental contamination [36].

Vaccination Strategies

Vaccination reduces the incidence of brucellosis and is a key component of eradication programs in endemic regions.

Brucella abortus Strain 19 (S19)

S19 is a live attenuated vaccine derived from a virulent B. abortus strain that lost virulence during laboratory passage [37]. It induces strong humoral and cell-mediated immunity. In cattle, a single dose (5–10 × 10^10 colony-forming units) given subcutaneously at 3–8 months of age provides 65–80% protection against abortion [38]. S19 elicits antibodies that persist for months, interfering with serological diagnosis [39]. Therefore, vaccination is typically restricted to young animals before sexual maturity, and test-and-slash is applied to adults.

Brucella abortus Strain RB51

RB51 is a rough mutant lacking O-polysaccharide, so vaccinated animals do not produce antibodies detectable by standard serological tests [40]. It is used in many countries for adult cattle vaccination. RB51 confers 70–90% protection but may cause abortion if administered to pregnant animals [41]. It is not effective in small ruminants.

Brucella melitensis Rev.1

Rev.1 is a live attenuated vaccine for sheep and goats. It protects against B. melitensis and B. ovis but induces persistent serological responses [42]. Rev.1 is administered conjunctivally to reduce interference with diagnostics [43].

Test-and-Slash Strategies

Test-and-slash (or test-and-remove) involves serological screening of herds, followed by slaughter of positive animals. This approach is effective when prevalence is low (<2%) and resources are available for compensation [44]. Serial testing with RBPT followed by ELISA or PCR improves positive predictive value [45]. In high-prevalence settings, vaccination is combined with test-and-slash to reduce the infected population [46].

The decision tree for a typical eradication program is shown below.

flowchart TD
    A[Herd Screening], > B{RBPT}
    B, >|Negative| C[No action]
    B, >|Positive| D[Confirmatory ELISA or PCR]
    D, >|Negative| C
    D, >|Positive| E[Test-and-slash: Remove animal]
    E, > F[Trace-back and trace-forward testing]
    F, > G[Quarantine and repeat herd test in 30-60 days]
    G, > A

Integration of Diagnostics in Eradication Programs

The choice of diagnostic algorithm depends on disease prevalence, vaccination status, and available infrastructure. In low-resource settings, RBPT alone may be used for screening, with ELISA confirmation on a subset [47]. In advanced programs, qPCR is used for early detection in milk tanks and for differentiating vaccine from field strains [48].

Cross-reactivity with other bacterial infections, such as those caused by Yersinia enterocolitica O:9, remains a challenge. The article on Salmonella enterica Serovar Typhimurium in Backyard Poultry Flocks discusses similar diagnostic interference issues. Additionally, the principles of molecular surveillance described in Porcine Reproductive and Respiratory Syndrome Coinfections with Bacterial Pathogens in Swine are applicable to brucellosis monitoring.

Conclusion

Brucellosis eradication in livestock requires a multi-faceted diagnostic approach. Serological tests (RBPT, ELISA) provide cost-effective screening, while molecular methods (PCR, qPCR) offer confirmatory and discriminatory power. Vaccination with S19 or RB51 reduces prevalence but complicates serological interpretation. Test-and-slash strategies are most effective when combined with accurate diagnostics and rigorous biosecurity. Continued development of point-of-care molecular assays and improved vaccine strains will further enhance eradication efforts.

References

[1] Corbel MJ. Brucellosis: an overview. Emerg Infect Dis. 1997;3(2):213-221.

[2] Godfroid J, Scholz HC, Barbier T, et al. Brucellosis at the animal/ecosystem/human interface at the beginning of the 21st century. Prev Vet Med. 2011;102(2):118-131.

[3] Carvalho Neta AV, Mol JP, Xavier MN, et al. Pathogenesis of bovine brucellosis. Vet J. 2010;184(2):146-155.

[4] McDermott JJ, Grace D, Zinsstag J. Economics of brucellosis impact and control in low-income countries. Rev Sci Tech. 2013;32(1):249-261.

[5] OIE. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. 12th ed. Paris: World Organisation for Animal Health; 2023.

[6] Bricker BJ. PCR as a diagnostic tool for brucellosis. Vet Microbiol. 2002;90(1-4):435-446.

[7] Roop RM 2nd, Bellaire BH, Valderas MW, Cardelli JA. Adaptation of the brucellae to their intracellular niche. Mol Microbiol. 2004;52(3):621-630.

[8] Cloeckaert A, Vizcaino N, Paquet JY, Bowden RA, Elzer PH. Major outer membrane proteins of Brucella spp.: past, present and future. Vet Microbiol. 2002;90(1-4):229-247.

[9] Schurig GG, Sriranganathan N, Corbel MJ. Brucellosis vaccines: past, present and future. Vet Microbiol. 2002;90(1-4):479-496.

[10] Adams LG. The pathology of brucellosis reflects the outcome of the battle between the host genome and the Brucella genome. Vet Microbiol. 2002;90(1-4):553-561.

[11] Baldwin CL, Goenka R. Host immune responses to the intracellular bacteria Brucella: does the bacteria instruct the host to facilitate chronic infection? Crit Rev Immunol. 2006;26(5):407-442.

[12] Nielsen K, Smith P, Yu WL, et al. Validation of a second generation competitive enzyme immunoassay (CELISA) for the detection of antibodies to Brucella abortus in bovine sera. J Immunol Methods. 1996;195(1-2):1-10.

[13] Alton GG, Jones LM, Angus RD, Verger JM. Techniques for the Brucellosis Laboratory. Paris: INRA; 1988.

[14] Nielsen K, Duncan JR. Animal Brucellosis. Boca Raton: CRC Press; 1990.

[15] Godfroid J, Nielsen K, Saegerman C. Diagnosis of brucellosis in livestock and wildlife. Croat Med J. 2010;51(4):296-305.

[16] OIE. Brucellosis (Brucella abortus, B. melitensis and B. suis). In: Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Paris: OIE; 2022.

[17] Nielsen K, Smith P, Yu WL, et al. Validation of an indirect enzyme immunoassay for detection of antibodies to Brucella abortus in bovine sera. J Immunoassay. 1994;15(1):61-74.

[18] Nielsen K, Smith P, Yu WL, et al. Competitive enzyme immunoassay for the detection of antibodies to Brucella abortus in bovine sera. J Immunoassay. 1995;16(2):147-162.

[19] Gall D, Nielsen K, Forbes L, et al. Validation of the fluorescence polarization assay and comparison to other serological assays for the detection of serum antibodies to Brucella abortus in bison. J Wildl Dis. 2000;36(3):469-476.

[20] Minas A, Stournara A, Minas M, et al. Validation of a competitive ELISA for diagnosis of Brucella melitensis infection in sheep and goats. Vet Microbiol. 2005;107(1-2):91-97.

[21] Nielsen K, Smith P, Yu WL, et al. Serological relationship between cattle exposed to Brucella abortus, Yersinia enterocolitica O:9 and Escherichia coli O:157. Vet Microbiol. 2004;100(1-2):25-30.

[22] MacMillan AP. Conventional serological tests for the diagnosis of brucellosis. In: Nielsen K, Duncan JR, eds. Animal Brucellosis. Boca Raton: CRC Press; 1990:153-197.

[23] OIE. Chapter 3.1.4: Brucellosis. In: Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Paris: OIE; 2022.

[24] Probert WS, Schrader KN, Khuong NY, Bystrom SL, Graves MH. Real-time multiplex PCR assay for detection of Brucella spp., B. abortus, and B. melitensis. J Clin Microbiol. 2004;42(3):1290-1293.

[25] Baily GG, Krahn JB, Drasar BS, Stoker NG. Detection of Brucella melitensis and Brucella abortus by DNA amplification. J Trop Med Hyg. 1992;95(4):271-275.

[26] Bricker BJ, Halling SM. Differentiation of Brucella abortus bv. 1, 2, and 4, Brucella melitensis, Brucella ovis, and Brucella suis bv. 1 by PCR. J Clin Microbiol. 1994;32(11):2660-2666.

[27] Newby DT, Hadfield TL, Roberto FF. Real-time PCR detection of Brucella abortus: a comparative study of SYBR Green I, 5'-exonuclease, and hybridization probe assays. Appl Environ Microbiol. 2003;69(8):4753-4759.

[28] Hinic V, Brodard I, Thomann A, et al. Novel identification and differentiation of Brucella melitensis, B. abortus, B. suis, B. ovis, B. canis, and B. neotomae suitable for routine use. J Clin Microbiol. 2008;46(6):2080-2087.

[29] García-Yoldi D, Marín CM, de Miguel MJ, et al. Multiplex PCR assay for the identification and differentiation of all Brucella species and the vaccine strains Brucella abortus S19 and RB51 and Brucella melitensis Rev1. Clin Chem. 2006;52(4):779-781.

[30] López-Goñi I, García-Yoldi D, Marín CM, et al. Evaluation of a multiplex PCR assay (Bruce-ladder) for molecular typing of all Brucella species, including the vaccine strains. J Clin Microbiol. 2008;46(10):3484-3487.

[31] Hamdy ME, Amin AS. Detection of Brucella species in the milk of infected cattle, sheep, goats and camels by PCR. Vet J. 2002;163(3):299-305.

[32] Leal-Klevezas DS, Martínez-Vázquez IO, López-Merino A, Martínez-Soriano JP. Single-step PCR for detection of Brucella spp. from blood and milk of infected animals. J Clin Microbiol. 1995;33(12):3087-3090.

[33] Romero C, Gamazo C, Pardo M, López-Goñi I. Specific detection of Brucella DNA by PCR. J Clin Microbiol. 1995;33(3):615-617.

[34] O'Leary S, Sheahan M, Sweeney T. Brucella abortus detection by PCR assay in blood, milk and tissue samples from cattle. Vet Microbiol. 2006;113(1-2):77-84.

[35] Mukherjee F, Jain J, Patel V, Nair M. Multiple genus-specific markers in PCR assays improve the specificity and sensitivity of detection of Brucella species in bovine samples. J Med Microbiol. 2007;56(Pt 10):1309-1316.

[36] Al Dahouk S, Nöckler K, Scholz HC, et al. Evaluation of genus-specific and species-specific real-time PCR assays for the identification of Brucella spp. Clin Chem Lab Med. 2007;45(11):1464-1470.

[37] Nicoletti P. Vaccination against Brucella. Adv Biotechnol Processes. 1990;13:147-168.

[38] Cheville NF, McCullough DR, Paulson LR. Brucellosis in the Greater Yellowstone Area. Washington, DC: National Academy Press; 1998.

[39] Olsen SC, Stoffregen WS. Essential role of vaccines in brucellosis control and eradication programs for livestock. Expert Rev Vaccines. 2005;4(6):915-928.

[40] Schurig GG, Roop RM 2nd, Bagchi T, et al. Biological properties of RB51; a stable rough strain of Brucella abortus. Vet Microbiol. 1991;28(2):171-188.

[41] Olsen SC, Evans D, Hennager SG, et al. Serologic responses of Brucella abortus strain 19 calfhood-vaccinated cattle following adult vaccination with strain RB51. J Vet Diagn Invest. 1996;8(4):451-454.

[42] Blasco JM. A review of the use of B. melitensis Rev 1 vaccine in adult sheep and goats. Prev Vet Med. 1997;31(3-4):275-283.

[43] Elberg SS. Rev 1 Brucella melitensis vaccine. Part II: 1968-1980. Vet Bull. 1981;51:67-73.

[44] Ragan VE. The Animal and Plant Health Inspection Service (APHIS) brucellosis eradication program in the United States. Vet Microbiol. 2002;90(1-4):11-18.

[45] Nielsen K, Gall D, Smith P, et al. Comparison of serological tests for the detection of antibodies to Brucella abortus in cattle. Vet Microbiol. 2004;100(1-2):1-10.

[46] Godfroid J, Garin-Bastuji B, Saegerman C, Blasco JM. Brucellosis in terrestrial wildlife. Rev Sci Tech. 2013;32(1):27-42.

[47] Mantur BG, Amarnath SK, Shinde RS. Review of clinical and laboratory features of human brucellosis. Indian J Med Microbiol. 2007;25(3):188-202.

[48] Kaden R, Ferrari S, Jinnerot T, et al. A novel real-time PCR assay for specific detection of Brucella melitensis. BMC Infect Dis. 2017;17(1):230.

[49] Poester FP, Samartino LE, Santos RL. Pathogenesis and pathobiology of brucellosis in livestock. Rev Sci Tech. 2013;32(1):105-115.

[50] Moreno E, Moriyón I. Brucella melitensis: a nasty bug with hidden credentials for virulence. Proc Natl Acad Sci USA. 2002;99(1):1-3.